1.Effect of nimodipine combined with minimally invasive puncture on neurological function,hemody-namics and serum inflammatory factor levels in patients with hypertensive intracerebral hemorrhage
Yangyang HU ; Changjuan WANG ; Jingjing DU ; Binglin GOU ; Long ZHANG ; Yang LIU ; Tengfei WANG
Journal of Xinxiang Medical College 2024;41(9):852-856,861
		                        		
		                        			
		                        			Objective To explore the effect of nimodipine combined with minimally invasive puncture on neurological function,hemodynamics,and serum inflammatory factor levels in patients with hypertensive intracerebral hemorrhage(HICH).Methods A total of 108 patients with HICH treated at the Second Affiliated Hospital of Hebei North University from June 2019 to May 2022 were selected as the research subjects.They were divided into an observation group(n=55)and a control group(n=53)according to the treatment method.All patients in the two groups received minimally invasive puncture;on this basis,the patients in the observation group were treated with nimodipine for one month.The neurological deficit of patients in the two groups was evaluated by the National Institute of Health Stroke Scale(NIHSS)score before and after treatment.Before and after treatment,5 mL of fasting venous blood was taken from patients in the morning,and the serum was obtained by centrifugation.The serum levels of brain-derived neurotrophic factor(BDNF),neuron-specific enolase(NSE),C-reactive protein(CRP),tumor necrosis factor-α(TNF-α)and interleukin-6(IL-6)were detected by enzyme-linked immunosorbent assay.Ultrasonic transcranial Doppler blood flow analyzer was used to monitor the hemodynamic indexes such as mean blood flow velocity(Vm),resistance index(RI)and pulsitility index(PI)of patients in the two groups before and after treatment.The adverse reactions such as headache,dizziness,infection and rebleeding were recorded in the two groups after treatment.Results There was no statistically significant difference in the NIHSS score and serum NSE and BDNF levels between the two groups before treatment(P>0.05).After treatment,the NIHSS score and serum NSE level of patients in the two groups were significantly lower than those before treatment,while the serum BDNF level was significantly higher than that before treatment(P<0.05).After treatment,the NIHSS score and serum NSE level of patients in the observation group were significantly lower than those in the control group,while the serum BDNF level was significantly higher than that in the control group(P<0.05).There was no statistically significant difference in the Vm,PI and RI between the two groups before treatment(P>0.05).After treatment,the Vm and PI of patients in the two groups were significantly higher than those before treatment,while the RI was significantly lower than that before treatment(P<0.05).After treatment,the Vm and PI of patients in the observa-tion group were significantly higher than those in the control group,while the RI was significantly lower than that in the control group(P<0.05).There was no statistically significant difference in serum TNF-α,IL-6,and CRP levels between the two groups before treatment(P>0.05).The levels of serum TNF-α,IL-6,and CRP of patients in the two groups after treatment were significantly lower than those before treatment(P<0.05).After treatment,serum TNF-α,IL-6,and CRP levels of patients in the observation group were significantly lower than those in the control group(P<0.05).The incidence of adverse reactions in patients in the control group and observation group was 7.55%(4/53)and 9.09%(5/55),respectively,and the difference in the incidence of adverse reactions between the two groups was not statistically significant(P>0.05).Conclusion Nimodipine combined with minimally invasive puncture can effectively improve the blood perfusion rate of HICH patients,reduce the degree of inflammatory response,and alleviate the patients'neurological function damage.
		                        		
		                        		
		                        		
		                        	
2.Biological parameters and cardiac physiological function of the mice overexpressing human Slit2 gene
Xiang LI ; Lingyun ZHENG ; Shuang ZHENG ; Weijiang TAN ; Jing WANG ; Binglin LI ; Ting LUO ; Ge LI ; Lijing WANG ; Fenghua YANG ; Ren HUANG
Acta Laboratorium Animalis Scientia Sinica 2018;26(3):302-310
		                        		
		                        			
		                        			Objective The basic biological, echocardiography and gene sequencing parameters of mice overexpressing Slit2 gene (Slit2-Tg mice) were collected and evaluated, and to provide a reference for the application of Slit2-Tg mice in biomedical research. Methods Slit2-Tg and C57BL/6 J mice were inbred. The genotypes of the mice were determined by a PCR assay. The blood samples were collected for blood routine and biochemical tests. The tissues of main organs were collected for protein expression and pathological analysis. Echocardiography and transcriptome sequencing was carried out for analyzing the heart function and gene expression, respectively. Results The litter size was significantly higher in the Slit2-Tg mice than in C57BL/6 J mice. Human Slit2 gene and protein expressions were detected in the main organs of Slit2-Tg mice. Organ coefficient of spleen was significantly increased in Slit2-Tg mice, but the tissue structure appeared normal. There were significant changes in the counts of erythrocytes, platelets, eosinophils, and biochemistry of glucose, globulin, urea nitrogen, triglycerides, HDL, and atherosclerosis index. Echocardiography showed no significant differences in the morphology and function of the Slit2-Tg hearts except in the left ventricular anterior wall thickness at the end-diastolic state. Compared with the C57BL/6 J mice, 535 genes out of 17513 genes in the Slit2-Tg hearts were increased or decreased, mainly involving 15 biological process or signal transduction pathways. Conclusions This study has collected the biological parameters of Slit2-Tg mice and suggests that this model animal is suitable for the studies of cardiovascular diseases.
		                        		
		                        		
		                        		
		                        	
3.Effect of different formula diets on mouse model with DEN-induced hepatocellular carcinoma
Xiaodong HE ; Yihe GUI ; Binglin LI ; Huijun DENG ; Jiangchao LI ; Lijing WANG
Acta Laboratorium Animalis Scientia Sinica 2017;25(3):306-310
		                        		
		                        			
		                        			Objective To establish a mouse model of diethylnitrosamine(DEN)-induced hepatocellular carcinoma (HCC),and to explore the effects of two different diet formulas on the establishment of DEN-induced HCC model.Methods SPF C57BL/6 mice (8 males and 8 females) were injected intraperitoneally with 25 mg/kg DEN at day 14 to establish a HCC model.The mice were divided into two groups after weaning.One group was fed with the SPF class rodents cereal-based diet,another group was fed with AIN-93G formula diet.The mice were sacrificed at the age of 9 months.The livers were weighed and the growth of liver cancer was observed and recorded.Results All the mice in the cereal-based diet group developed HCC as expected.The body weight and liver mass of the mice in the AIN-93G diet group were significantly lower than that of the cereal-based diet group.The incidence of HCC,and the number and size of tumor nodules were also significantly lower in the AIN-93G diet group than that in the cereal-based diet group.Conclusions DEN-induced HCC model has been successfully established in mice fed with cereal-based diet,while mice fed with AIN93-G diet prevented the development of DEN-induced HCC,and their body weight was decreased significantly,suggesting that dietary factors play a key role in establishment of animal disease models.
		                        		
		                        		
		                        		
		                        	
4.Clinical Research Guidelines for Treatment of Osteoporosis with New Uyghur Medicine (Draft)
Abudukelimu ABUDUWAILI ; Aibai SILAFU ; Pingshan WANG ; Maitinuer YUSUFU ; Wusiman MUHAMAITI ; Hong ZHANG ; Liansheng BAI ; Jinfeng LI ; Zhijian LI ; Abuduaini ABUDUJILILI ; Gongshu LI ; Binglin LIU ; Xiaojing PEI ; Bei ZHOU
Chinese Journal of Information on Traditional Chinese Medicine 2017;24(10):1-4
		                        		
		                        			
		                        			In this study, retrospective multi-center study on medical records of Uyghur medicine diagnosis and treatment program of osteoporosis was done and demographic, diagnostic, therapeutic, efficacy evaluation and nursing data and other information were collected. The main and secondary disease manifestations of osteoporosis were analyzed inductively. Osteoporosis was divided into 2 types in Uyghur medicine field, which were abnormal Savda type and abnormal Balgham type. Uighur medicine syndrome type standards of osteoporosis were established. Treatment efficacy was evaluated according to bone pain, bone density, life quality, and improvement of clinical symptoms and Uyghur medical symptoms. On this basis, in accordance with the technical requirements of the national drug review, the study developed clinical research guidelines for the treatment of osteoporosis with new Uyghur medicine (draft).
		                        		
		                        		
		                        		
		                        	
5.Clinical Research Guidelines for Treatment of Acne Vulgaris with New Uyghur Medicine ;(Draft)
Abudukelimu ABUDUWAILI ; Aibai SILAFU ; Pingshan WANG ; Wufuer TUERXUN ; Maitinuer YUSUFU ; Wusiman MUHAMAITI ; Hong ZHANG ; Aximu TUERHONG ; Liansheng BAI ; Jinfeng LI ; Maihemute GUHAER ; Abuduaini ABUDUJILILI ; Zhijian LI ; Gongshu LI ; Binglin LIU ; Xiaojing PEI ; Bei ZHOU
Chinese Journal of Information on Traditional Chinese Medicine 2017;24(2):1-4
		                        		
		                        			
		                        			In this article, retrospective multi-center study on medical records of Uyghur Medicine diagnosis and treatment program of acne vulgaris was done and demographic, diagnostic, therapeutic, efficacy evaluation and nursing data and other information were collated and analyzed. The main and secondary disease manifestations of acne vulgaris were analyzed inductively and acne vulgaris was divided into 3 types in Uyghur Medicine field, which are blood-type acne vulgaris, yellow bile-type acne vulgaris, and astringent mucus-type acne vulgaris. Uyghur Medicine syndrome type standards of acne vulgaris were established. At the same time, through evaluating skin integrity and morphology of lesions as well as changes in patients’ symptoms and quality of life and observing changes in patients’ internal environment respectively before and after treatment, disease and syndrome clinical criteria of acne vulgaris were established. On this basis, in accordance with the technical requirements of the national medicine review, this study developed clinical research guidelines for the treatment of acne vulgaris with new Uyghur Medicine.
		                        		
		                        		
		                        		
		                        	
6.Clinical Research Guidelines for Treatment of Common Cold with New Uyghur Medicine (Draft)
Abudukelimu ABUDUWAILI ; Aibai SILAFU ; Pingshan WANG ; Maitinuer YUSUFU ; Wusiman MUHAMAITI ; Maimaiti MAINISHA ; Aximu TUERHONG ; Hong ZHANG ; Liansheng BAI ; Jinfeng LI ; Zhijian LI ; Abuduaini ABUDUJILILI ; Gongshu LI ; Binglin LIU ; Xiaojing PEI ; Bei ZHOU
Chinese Journal of Information on Traditional Chinese Medicine 2017;24(5):1-4
		                        		
		                        			
		                        			In this study, retrospective multi-center study on medical records of Uyghur Medicine diagnosis and treatment program of common cold was done and demographic, diagnostic, therapeutic, efficacy evaluation and nursing data and other information were collected, sorted out and analyzed to determine the diagnostic cretiria of Uygur Medicine syndrome factors. Syndrome differentiation standard with the syndrome factors of the enrties of main syndromes and sub-syndromes and symptomatic diagnosis chart was established. Combined with the symptoms of common cold, the efficacy evaluation standards were established. On this basis, in accordance with the technical requirements of the national new medicine review, the study developed clinical research guidelines for the treatment of common cold with new Uyghur Medicine (draft).
		                        		
		                        		
		                        		
		                        	
7.Clinical Research Guidelines for Treatment of Shingles with New Uyghur Medicine (Draft)
Abudukelimu ABUDUWAILI ; Aibai SILAFU ; Pingshan WANG ; Wufuer TUERXUN ; Maitinuer YUSUFU ; Wusiman MUHAMAITI ; Hong ZHANG ; Aximu TUERHONG ; Saimaiti REFUHATI ; Liansheng BAI ; Jinfeng LI ; Abuduaini ABUDUJILILI ; Zhijian LI ; Gongshu LI ; Binglin LIU ; Xiaojing PEI ; Bei ZHOU
Chinese Journal of Information on Traditional Chinese Medicine 2017;24(1):1-4
		                        		
		                        			
		                        			This research conducted retrospective multi-center study on medical records of Uyghur Medicine diagnosis and treatment program of shingles, and collected information about demography, diagnostics, and therapeutics, efficacy evaluation and nursing to conclude and analyze the main syndromes and sub-disease performance. Shingles was divided into 3 types in Uyghur Medicine field: abnormal blood type shingles, abnormal bile liquid type shingles, and abnormal black choledochal typeshingles. Uighur Medicine syndrome type standards of shingles were established. Rash suspended time, rash dry scab time, the pain start to ease time interval, time completely pain, pain bounce rate, the incidence of postherpetic neuralgia, and PHN recovery time were evaluated. Disease and syndrome clinical criteria of shingles were established by evaluating Uygur Medical symptoms improvement, improvement of patients’ life quality and the changes in patients’ internal environment. On this basis, in accordance with the technical requirements of the national medicine review, the research developed clinical research guidelines for the treatment of shingles with new Uyghur Medicine (draft).
		                        		
		                        		
		                        		
		                        	
8.Serum metabolic changes in a transgenic mouse model of Alzheimer's disease
Binglin LI ; Xin LU ; Jiangchao LI ; Jia WANG ; Lijing WANG ; Yongxia YANG
Acta Laboratorium Animalis Scientia Sinica 2017;25(2):218-224
		                        		
		                        			
		                        			Objective To provide a basis for clinical diagnosis,a serum metabonomic dynamic study was carried out on the Tg2576 mouse model at different stages of Alzheimer's disease(AD) whose pathological progress is similar to that of human AD patients.Methods Serum samples of Tg2576 mice were collected at the early(6 months) and late(12 months) stages of Alzheimer's disease.The 1H NMR spectra of the serum samples were collected and the metabolic characteristics were analyzed by multivariate analysis.Results Significant differences in serum metabonomics were found in the transgenic Tg2576 mice and C57 mice at 6 and 12 months of age,and there were significant metabolic changes in Tg2576 mice at different stages of Alzheimer's disease.Compared with C57 mice,the Tg2576 mice at early stage of Alzheimer's disease showed higher levels of serum lactate,myo-inositol and amino acids(such as leucine,isoleucine,alanine),and lower levels of lipids,choline,phosphorylcholine,glycerol phosphorglcholine,betaine,glycine and glucose.At the late stage of Alzheimer's disease,the transgenic Tg2576 mice had higher levels of lactate,myo-inositol and alanine,while the serum levels of lipids,choline,phosphorylcholine,glycerophosphorylcholine,betaine,and glycine continued to drop.Meanwhile glutamine and creatine levels started to decline.By comparing the early and late serum metabolites of Alzheimer's disease,serum metabonomic profiles of the late stage of Alzheimer's disease indicated an up-regulation of lactate,myo-inositol and alanine,and a down-regulation of lipids,choline,phosphorylcholine and glycerophosphorylcholinelevels.Moreover,the levels of lactate,lipids,choline,phosphorylcholine and glycerophosphorylcholine showed statistical significance at the early stage of AD,and they were closely correlated with the severity of Alzheimer's disease.Conclusions The above results show that the changes of lactate,myo-inositol and alanine are positively-correlated with the development of AD,while the serum levels of lipids,choline,phosphorylcholine and glycerophosphorylcholine are inversely-proportional to the severity of AD.These metabolites are dynamically and progressively changed along with the disease progression,which hopefully may serve as early metabolic markers for the diagnosis of AD in clinical practice.
		                        		
		                        		
		                        		
		                        	
9.Clinical Research Guidelines for Treatment of Hyperlipidemia with New Uyghur Medicine (Draft)
Abudukelimu ABUDUWAILI ; Aibai SILAFU ; Pingshan WANG ; Wufuer ASIYA ; Maitinuer YUSUFU ; Wusiman MUHAMAITI ; Maimaiti MAINISHA ; Aximu TUERHONG ; Hong ZHANG ; Liansheng BAI ; Jinfeng LI ; Zhijian LI ; Abuduaini ABUDUJILILI ; Gongshu LI ; Binglin LIU ; Xiaojing PEI ; Bei ZHOU
Chinese Journal of Information on Traditional Chinese Medicine 2017;24(6):1-5
		                        		
		                        			
		                        			Based on medical ethics, retrospective multi-center study on medical records of Uyghur Medicine diagnosis and treatment program of hyperlipidemia was done and demographic, diagnostic, therapeutic, efficacy evaluation, nursing data and other information were collated. The main and secondary disease manifestations of hyperlipidemia were analyzed inductively and hyperlipidemia were divided into 4 types in Uyghur Medicine field, which were surplus and sticky Kan type, Chuchumal Balgham type, Gaisiman Balgham type, and Koygan Savda type. Therefore, Uighur Medicine syndrome type standards of hyperlipidemia were established. Treatment efficacy was evaluated with the combination of laboratory observation parameters and main and secondary disease manifestations. On this basis, in accordance with the technical requirements of the national medicine review, this study developed clinical research guidelines for the treatment of hyperlipidemia with new Uyghur Medicine (draft).
		                        		
		                        		
		                        		
		                        	
10.Clinical Study onErxian Decoction Combined with Elcatonin in the Treatment of Postmenopausal Osteoporosis
Binglin YE ; Shenghua LI ; Shuling LI ; Xiangfu WANG ; Fengqi SUN ; Yuxia WEN
Chinese Journal of Information on Traditional Chinese Medicine 2016;23(6):23-26
		                        		
		                        			
		                        			Objective To observe the clinical efficacy ofErxian Decoction combined with elcatonin for the treatment of postmenopausal osteoporosis.Methods Eighty cases of female patients with postmenopausal osteoporosis were randomly divided into treatment group and control group, 40 cases in each group. The control group received intramuscular injections elcatonin treatment, and the treatment group received oralErxian Decoction on the basis of the treatment of the control group, for 12 weeks. The main clinical symptom score, VAS score and bone mineral density (BMD) of L2-L4 and in the tibia of the two groups were observed before and after treatment to assess the therapeutic effect.Results After treatment, VAS scores of the two groups were significantly lower (P<0.05). The total effective rate of the treatment group was 92.5% (37/40); the control group was 75.0 (30/40), with statistical significance (P<0.05). The treatment group was significantly better than the control group in main symptom scores, especially in improving body symptoms (P<0.05). BMD of the treatment group was significantly higher than the control group.ConclusionErxian Decoction combined with elcatonin therapy for postmenopausal women with osteoporosis can significantly improve clinical symptoms and increase BMD.
		                        		
		                        		
		                        		
		                        	
            
Result Analysis
Print
Save
E-mail